Polyrizon Ltd (PLRZ)

Jan 10, 2026

Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 10, 2026

Jan 10, 2026

Can Polyrizon Ltd. stock rebound after recent weaknessPortfolio Gains Report & Technical Pattern Recognition Alerts - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Is Polyrizon Ltd. stock undervalued vs historical averagesNew Releases Roundup & what to check before ordering - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Why Polyrizon Ltd. stock is favored by top institutions2025 Winners & Losers & Fast Moving Trade Plans - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Polyrizon expects Nasarix introduction aligned with clinical progress - MarketScreener

Jan 08, 2026

Jan 08, 2026

Polyrizon names allergy blocker product NASARIX - Investing.com

Jan 08, 2026

Jan 08, 2026

Polyrizon Brands PL-14 Intranasal Allergy Blocker as NASARIX™ - TipRanks

Jan 08, 2026

Jan 08, 2026

Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™ - The Manila Times

Jan 08, 2026

Jan 08, 2026

Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX - Bluefield Daily Telegraph

Jan 08, 2026

Jan 08, 2026

NASARIX: a new nasal spray brand designed to shield against allergens - Stock Titan

Jan 08, 2026

Jan 05, 2026

Polyrizon’s PL-14 shows strong pre-clinical allergen-blocking advantage over standard nasal barrier - MSN

Jan 05, 2026

Jan 05, 2026

Polyrizon announces in-vitro results for PL-16 Viral Blocker - MSN

Jan 05, 2026

Jan 05, 2026

Polyrizon stock rises after positive pre-clinical allergy blocker results By Investing.com - Investing.com Nigeria

Jan 05, 2026

Jan 05, 2026

Polyrizon stock rises after positive pre-clinical allergy blocker results - Investing.com

Jan 05, 2026

Jan 05, 2026

Polyrizon Announces Positive Data From PL-14 Allergy Blocker Formulation Study - Nasdaq

Jan 05, 2026

Jan 05, 2026

Polyrizon’s nasal allergy blocker outperforms standard in lab study By Investing.com - Investing.com South Africa

Jan 05, 2026

Jan 05, 2026

Polyrizon’s PL-14 Shows Strong Pre-Clinical Allergen-Blocking Advantage Over Standard Nasal Barrier - TipRanks

Jan 05, 2026

Jan 05, 2026

Polyrizon’s nasal allergy blocker outperforms standard in lab study - Investing.com India

Jan 05, 2026

Jan 05, 2026

Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator - The Manila Times

Jan 05, 2026

Jan 05, 2026

Lab test hints at new nasal barrier to block dust mite allergy triggers - Stock Titan

Jan 05, 2026

Jan 03, 2026

Polyrizon submits pre-request to FDA for nasal spray against flu - Investing.com Nigeria

Jan 03, 2026

Jan 02, 2026

Polyrizon submits pre-request to FDA for nasal spray against flu By Investing.com - Investing.com South Africa

Jan 02, 2026

Jan 02, 2026

Polyrizon stock rises on FDA submission for PL-16 viral blocker - Investing.com Australia

Jan 02, 2026

Jan 02, 2026

As Flu Surge Continues, Polyrizon's Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated - The Manila Times

Jan 02, 2026

Jan 02, 2026

Could a simple nasal spray add a drug-free layer of flu protection? - Stock Titan

Jan 02, 2026

Dec 31, 2025

Polyrizon (PLRZ) Stock Analysis Report | Financials & Insights - Benzinga

Dec 31, 2025

Dec 30, 2025

Polyrizon reports mucoadhesion results for intranasal naloxone hydrogel - MSN

Dec 30, 2025

Dec 30, 2025

Polyrizon Ltd. to Explore Investment Opportunities in Revenue-Generating Real Assets - MarketScreener

Dec 30, 2025

Dec 30, 2025

Polyrizon to explore investments in revenue-generating assets By Investing.com - Investing.com Nigeria

Dec 30, 2025

Dec 29, 2025

Polyrizon to pursue revenue-generating real assets while advancing intranasal biotech pipeline - MSN

Dec 29, 2025

Dec 29, 2025

Polyrizon stock rises as company explores revenue-generating investments By Investing.com - Investing.com Nigeria

Dec 29, 2025

Dec 29, 2025

symbol__ Stock Quote Price and Forecast - CNN

Dec 29, 2025

Dec 29, 2025

Polyrizon to explore investment in revenue-generating real assets - marketscreener.com

Dec 29, 2025

Dec 29, 2025

Polyrizon to Pursue Revenue-Generating Real Assets While Advancing Intranasal Biotech Pipeline - TipRanks

Dec 29, 2025

Dec 29, 2025

Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet - The Manila Times

Dec 29, 2025

Dec 29, 2025

Biotech with no debt looks beyond the lab to buy real assets - Stock Titan

Dec 29, 2025

Dec 27, 2025

Polyrizon completes manufacturing upscaling milestone for nasal spray platform - MSN

Dec 27, 2025

Dec 27, 2025

Top Medical Stocks To Keep An Eye OnDecember 2nd - MarketBeat

Dec 27, 2025

Dec 26, 2025

What risks investors should watch in Polyrizon Ltd. stockPortfolio Performance Report & Fast Gain Stock Trading Tips - moha.gov.vn

Dec 26, 2025

Dec 26, 2025

Biotech alert: Searches spiking for these stocks today - MSN

Dec 26, 2025

Dec 24, 2025

Polyrizon Achieves Key Manufacturing Milestone for Nasal Spray Platform - MSN

Dec 24, 2025

Dec 23, 2025

Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray - MSN

Dec 23, 2025

Dec 23, 2025

Polyrizon unveils promising results for intranasal naloxone hydrogel - MSN

Dec 23, 2025